| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/27/2004 | WO2004043433A2 Pharmaceutical antiviral compositions |
| 05/27/2004 | WO2004043432A2 Controlled release depot formulations |
| 05/27/2004 | WO2004043431A1 Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or bucally |
| 05/27/2004 | WO2004043430A2 Botulinum toxin formulations for oral administration |
| 05/27/2004 | WO2004043428A2 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/27/2004 | WO2004043427A1 Palatable carrier for medicine for an animal |
| 05/27/2004 | WO2004043426A1 Multi-layer transmucosal therapeutic system |
| 05/27/2004 | WO2004043425A1 Implant, therapeutic agent and micelle |
| 05/27/2004 | WO2004043407A2 Methods and products for treating staphylococcal infections |
| 05/27/2004 | WO2004043393A2 Compositions for diabetes treatment and prophylaxis |
| 05/27/2004 | WO2004043390A2 Pharmaceutical compositions and methods of using taxane derivatives |
| 05/27/2004 | WO2004043389A2 Methods of treating cancer and related methods |
| 05/27/2004 | WO2004043388A2 Chewing gum with encapsulated stain removing agent |
| 05/27/2004 | WO2004043387A2 Compositions and methods for cancer diagnosis and therapy |
| 05/27/2004 | WO2004043375A2 Pharmaceutical compositions and methods of using taxane derivatives |
| 05/27/2004 | WO2004043363A2 Protein-stabilized liposomal formulations of pharmaceutical agents |
| 05/27/2004 | WO2004043358A2 Formulations of low solubility bioactive agents and processes for making the same |
| 05/27/2004 | WO2004043356A2 Coated dibasic calcium phosphate |
| 05/27/2004 | WO2004043351A2 Soluble oral patch with collagen and interlaced active ingredients |
| 05/27/2004 | WO2004043166A1 Use of branched malto-dextrins as granulation binders |
| 05/27/2004 | WO2004043165A1 Edible film containing food acid |
| 05/27/2004 | WO2004043164A2 Extruded foodstuffs having maintenance level actives |
| 05/27/2004 | WO2004043140A2 Nutraceuticals and method of feeding aquatic animals |
| 05/27/2004 | WO2004037311A3 Device and methods for sequential, regional delivery of multiple cytotoxic agents |
| 05/27/2004 | WO2004034943A3 Process and reactor for the manufacture of powders of inhalable medicaments |
| 05/27/2004 | WO2004026233A3 Mannitol formulation for integrin receptor antagonist |
| 05/27/2004 | WO2004024187A3 Compositions to reduce congestion and methods for application thereof to the nasal membrane |
| 05/27/2004 | WO2004021968A3 Solution for ungual application |
| 05/27/2004 | WO2004007520A3 Methods and compositions for preventing oxidative degradation of proteins |
| 05/27/2004 | WO2004004725A3 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 05/27/2004 | WO2003105611B1 Beverages containing plant sterols |
| 05/27/2004 | WO2003099992A3 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 05/27/2004 | WO2003088985A8 Use of compositions containing petasites for treating diseases |
| 05/27/2004 | WO2003065928A9 Therapeutic polyesters and polyamides |
| 05/27/2004 | WO2003006034A3 Herbal formulation |
| 05/27/2004 | WO2003006002A8 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 05/27/2004 | WO2003000295A3 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 05/27/2004 | WO2002085304A3 Proliposomal drug delivery system |
| 05/27/2004 | WO2002058673A8 Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine |
| 05/27/2004 | US20040102762 Osmotic delivery device having a two-way valve and dynamically self-adjusting flow channel |
| 05/27/2004 | US20040102759 Method of treating coronary arteries with perivascular delivery of therapetic agents |
| 05/27/2004 | US20040102652 For treatment of cardiovascular disorders/heart failure |
| 05/27/2004 | US20040102522 Dosage form of sodium ibuprofen |
| 05/27/2004 | US20040102504 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 05/27/2004 | US20040102502 Preventing/remedies for portal hypertension |
| 05/27/2004 | US20040102476 High concentration formulations of opioids and opioid derivatives |
| 05/27/2004 | US20040102468 Controlling discharge of urine |
| 05/27/2004 | US20040102434 Method for treating pain with loxapine and amoxapine |
| 05/27/2004 | US20040102429 Zinc salt compositions for the prevention of dermal and mucosal irritation |
| 05/27/2004 | US20040102422 Administering human papillomaviruse protein; urogenital cancer therapy |
| 05/27/2004 | US20040102415 Diffusion of aqueous brine solution containing antioxidant and arginine; fluid flow circuits |
| 05/27/2004 | US20040102411 DNA vaccine against feline immunodeficiency virus |
| 05/27/2004 | US20040102408 Method and medicament for inhibiting the expression of a given gene |
| 05/27/2004 | US20040102366 A homogeneous cyclosporin solution comprising a carrier dialkyl ester of aliphatic or aromatic dioic acid, hydrophilic lipophilic balance, forming emulsions in stomach with gastrointestinal fluids |
| 05/27/2004 | US20040102358 Composition for treating skin conditions |
| 05/27/2004 | US20040102317 Catalyst and its use in desulphurisation |
| 05/27/2004 | US20040101919 Detecting cell wall anchored surface proteins and developing vaccines to diagnose, prevent and treat enterococcus, streptococcus, staphylococcus and bacillus infections |
| 05/27/2004 | US20040101596 Infant formula |
| 05/27/2004 | US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer |
| 05/27/2004 | US20040101573 Injectable composition for cancer treatment |
| 05/27/2004 | US20040101568 Microgranules based on active principle and method for making same |
| 05/27/2004 | US20040101567 Granular preparations for oral administration |
| 05/27/2004 | US20040101566 Novel benzoyl peroxide compositions |
| 05/27/2004 | US20040101565 Mehtod to obtain microparticles containing a h+ k+ atp-ase inhibitor |
| 05/27/2004 | US20040101564 Embolization |
| 05/27/2004 | US20040101563 Storage stable antihistaminic syrup formulations |
| 05/27/2004 | US20040101562 Enzyme encapsulated in hydrophilic low melting polymer; bioavailability |
| 05/27/2004 | US20040101561 Combinations of viscoelastics for use during surgery |
| 05/27/2004 | US20040101560 Methods and compositions for applying pharmacologic agents to the ear |
| 05/27/2004 | US20040101559 Polymer, clay composite; mixing, pressurization the blend, firing |
| 05/27/2004 | US20040101558 Drug with enteric coating; oral administering |
| 05/27/2004 | US20040101557 Sustained release of active materials; storage stability |
| 05/27/2004 | US20040101556 Stable pharmaceutical compositions without a stabilizer |
| 05/27/2004 | US20040101555 Stabilization by mixing with desiccant; encapsulated in polymer; dietetics; appeptite suppressants |
| 05/27/2004 | US20040101554 Fatty acid in soft gelatin capsule; plant and animal extracts; controlling taste |
| 05/27/2004 | US20040101553 Complex of liposome and platinum compound |
| 05/27/2004 | US20040101552 Pharmaceutical compositions |
| 05/27/2004 | US20040101551 Transdermal therapeutic system for releasing venlafaxine |
| 05/27/2004 | US20040101550 Transdermal therapeutic system |
| 05/27/2004 | US20040101549 Transdermal administering estrogen |
| 05/27/2004 | US20040101540 Oral delivery system and method for making same |
| 05/27/2004 | US20040101538 Synergistic mixture of terbinafine with diclofenac or indomethacin; fungicide |
| 05/27/2004 | US20040101537 Mixture of oligonucleotide and fine particles of biodegradation polymer; concurrent administering of protein antigen |
| 05/27/2004 | US20040101506 Composition for the prevention and treatment of inflammation of the ear |
| 05/27/2004 | US20040101494 Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
| 05/27/2004 | US20040101493 Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
| 05/27/2004 | US20040101487 Combinations of formoterol and fluticasone propionate for asthma |
| 05/27/2004 | US20040101486 Budesonide for diseases of nose, respiratory system disorders |
| 05/27/2004 | US20040101485 Kidney and liver diseases; antiarthritic agents; antidepressants; Alzheimer's disease; Parkinson's disease; cardiovascular disorders; anticancer agents |
| 05/27/2004 | US20040101484 Nasal delivery of apomorphine in combination with glycol derivatives |
| 05/27/2004 | US20040101483 Mixture of drug with aerosol propellant; supplying lungs |
| 05/27/2004 | US20040101482 Medicaments |
| 05/27/2004 | US20040101481 Inhalation therapy |
| 05/27/2004 | US20040101480 Injectable foam; blood dispersion of gases; cardiovascular disorders |
| 05/27/2004 | US20040099976 Encapsulating liposomes; using phosphatides, glycolipid with carbon dioxide under supercritical conditions |
| 05/27/2004 | US20040099612 Method and apparatus for filtering and drying a product |
| 05/27/2004 | US20040099269 Drug condensation aerosols and kits |
| 05/27/2004 | US20040098839 Crystallization method and apparatus using an impinging plate assembly |
| 05/27/2004 | CA2512033A1 Shape-retentive hydrogel particle aggregates and their uses |
| 05/27/2004 | CA2505951A1 Oral testosterone delivery system with improved sustained release |